Panosyan E - Search Results

1

A microfluidic platform for systems pathology: multiparameter single-cell signaling measurements of clinical brain tumor specimens.

Sun J, Masterman-Smith MD, Graham NA, Jiao J, Mottahedeh J, Laks DR, Ohashi M, DeJesus J, Kamei K, Lee KB, Wang H, Yu ZT, Lu YT, Hou S, Li K, Liu M, Zhang N, Wang S, Angenieux B, Panosyan E, Samuels ER, Park J, Williams D, Konkankit V, Nathanson D, van Dam RM, Phelps ME, Wu H, Liau LM, Mischel PS, Lazareff JA, Kornblum HI, Yong WH, Graeber TG, Tseng HR. Sun J, et al. Among authors: panosyan e. Cancer Res. 2010 Aug 1;70(15):6128-38. doi: 10.1158/0008-5472.CAN-10-0076. Epub 2010 Jul 14. Cancer Res. 2010. PMID: 20631065 Free PMC article.

2

Clinical outcome in pediatric glial and embryonal brain tumors correlates with in vitro multi-passageable neurosphere formation.

Panosyan EH, Laks DR, Masterman-Smith M, Mottahedeh J, Yong WH, Cloughesy TF, Lazareff JA, Mischel PS, Moore TB, Kornblum HI. Panosyan EH, et al. Pediatr Blood Cancer. 2010 Oct;55(4):644-51. doi: 10.1002/pbc.22627. Pediatr Blood Cancer. 2010. PMID: 20589659 Free PMC article.

3

High-dose chemotherapy with autologous hematopoietic stem-cell rescue for pediatric brain tumor patients: a single institution experience from UCLA.

Panosyan EH, Ikeda AK, Chang VY, Laks DR, Reeb CL, Bowles LV, Lasky JL 3rd, Moore TB. Panosyan EH, et al. J Transplant. 2011;2011:740673. doi: 10.1155/2011/740673. Epub 2011 Apr 14. J Transplant. 2011. PMID: 21559259 Free PMC article.

4

A molecular screening approach to identify and characterize inhibitors of glioblastoma stem cells.

Visnyei K, Onodera H, Damoiseaux R, Saigusa K, Petrosyan S, De Vries D, Ferrari D, Saxe J, Panosyan EH, Masterman-Smith M, Mottahedeh J, Bradley KA, Huang J, Sabatti C, Nakano I, Kornblum HI. Visnyei K, et al. Mol Cancer Ther. 2011 Oct;10(10):1818-28. doi: 10.1158/1535-7163.MCT-11-0268. Epub 2011 Aug 22. Mol Cancer Ther. 2011. PMID: 21859839 Free PMC article.

5

Autologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas.

Lasky JL 3rd, Panosyan EH, Plant A, Davidson T, Yong WH, Prins RM, Liau LM, Moore TB. Lasky JL 3rd, et al. Anticancer Res. 2013 May;33(5):2047-56. Anticancer Res. 2013. PMID: 23645755 Free PMC article.

6

Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumors.

Panosyan EH, Wang Y, Xia P, Lee WN, Pak Y, Laks DR, Lin HJ, Moore TB, Cloughesy TF, Kornblum HI, Lasky JL 3rd. Panosyan EH, et al. Mol Cancer Res. 2014 May;12(5):694-702. doi: 10.1158/1541-7786.MCR-13-0576. Epub 2014 Feb 6. Mol Cancer Res. 2014. PMID: 24505127 Free PMC article.

7

Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: a report from Children's Oncology Group Study CCG-1962.

Avramis IA, Panosyan EH, Dorey F, Holcenberg JS, Avramis VI; Children's Oncology Group. Avramis IA, et al. Clin Cancer Res. 2006 Dec 1;12(23):6978-84. doi: 10.1158/1078-0432.CCR-06-1140. Clin Cancer Res. 2006. PMID: 17145817

8

Allergic reactions and antiasparaginase antibodies in children with high-risk acute lymphoblastic leukemia: A children's oncology group report.

Ko RH, Jones TL, Radvinsky D, Robison N, Gaynon PS, Panosyan EH, Avramis IA, Avramis VI, Rubin J, Ettinger LJ, Seibel NL, Dhall G. Ko RH, et al. Cancer. 2015 Dec 1;121(23):4205-11. doi: 10.1002/cncr.29641. Epub 2015 Aug 26. Cancer. 2015. PMID: 26308766 Free PMC article.

9

In search of druggable targets for GBM amino acid metabolism.

Panosyan EH, Lin HJ, Koster J, Lasky JL 3rd. Panosyan EH, et al. BMC Cancer. 2017 Feb 28;17(1):162. doi: 10.1186/s12885-017-3148-1. BMC Cancer. 2017. PMID: 28245795 Free PMC article.

10

Efficacy of Asparaginase Erwinia chrysanthemi With and Without Temozolomide Against Glioma Cells and Intracranial Mouse Medulloblastoma.

Sanghez V, Chen M, Li S, Chou TF, Iacovino M, Lin HJ, Lasky JL, Panosyan EH. Sanghez V, et al. Anticancer Res. 2018 May;38(5):2627-2634. doi: 10.21873/anticanres.12504. Anticancer Res. 2018. PMID: 29715082

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters